| Literature DB >> 30797774 |
Jesse C Patterson1, Brian A Joughin2, Bert van de Kooij1, Daniel C Lim1, Douglas A Lauffenburger3, Michael B Yaffe4.
Abstract
Although elevated levels of reactive oxygen species (ROS) have been observed in cancer cells and cancer cells aberrantly proliferate, it is not known whether the level of reactive oxygen species and the accumulation of oxidative damage to macromolecules vary across the cell cycle. Here, we measure the prevalence of reactive oxygen species and of biomolecule oxidation across the cell cycle in freely cycling cancer cells. We report that reactive oxygen species vary during the cell cycle and peak in mitosis, resulting in mitotic accumulation of oxidized protein cysteine residues. Prolonged mitotic arrest further increased the levels of ROS and the abundance of oxidatively damaged biomolecules, including cysteine-sulfenic-acid-containing proteins and 8-oxoguanine. These finding suggest that mitotic arrest agents may enhance the effects of ROS-dependent anticancer therapies.Entities:
Keywords: 8-oxoguanine; ROS; antimitotic cancer therapy; cell cycle; docetaxel; mitosis; mitotic arrest; oxidative DNA damage; protein cysteine oxidation; reactive oxygen species
Year: 2019 PMID: 30797774 PMCID: PMC6688173 DOI: 10.1016/j.cels.2019.01.005
Source DB: PubMed Journal: Cell Syst ISSN: 2405-4712 Impact factor: 10.304